Profile | GDS5420 / 210399_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 87.53 | 40 |
GSM1296119 | B_lesional_pre-dose | 26.86 | 20 |
GSM1296076 | C_lesional_pre-dose | 106.35 | 43 |
GSM1296092 | D_lesional_pre-dose | 145.78 | 49 |
GSM1296103 | E_lesional_pre-dose | 160.75 | 49 |
GSM1296078 | F_lesional_pre-dose | 85.66 | 40 |
GSM1296107 | G_lesional_pre-dose | 68.61 | 34 |
GSM1296109 | H_lesional_pre-dose | 135.19 | 45 |
GSM1296080 | I_lesional_pre-dose | 41.39 | 30 |
GSM1296090 | J_lesional_pre-dose | 124.14 | 46 |
GSM1296074 | K_lesional_pre-dose | 111.1 | 46 |
GSM1296111 | L_lesional_pre-dose | 85.29 | 36 |
GSM1296099 | M_lesional_pre-dose | 136.19 | 46 |
GSM1296086 | O_lesional_pre-dose | 341.3 | 62 |
GSM1296117 | P_lesional_pre-dose | 118.64 | 42 |
GSM1296113 | Q_lesional_pre-dose | 78.99 | 34 |
GSM1296096 | R_lesional_pre-dose | 203.88 | 53 |
GSM1296105 | S_lesional_pre-dose | 77.8 | 37 |
GSM1296098 | T_lesional_pre-dose | 100.09 | 40 |
GSM1296101 | U_lesional_pre-dose | 65.14 | 35 |
GSM1296121 | V_lesional_pre-dose | 49.72 | 29 |
GSM1296088 | W_lesional_pre-dose | 102.09 | 43 |
GSM1296082 | X_lesional_pre-dose | 366.01 | 63 |
GSM1296115 | Y_lesional_pre-dose | 104.88 | 41 |
GSM1296084 | Z_lesional_pre-dose | 84.47 | 39 |
GSM1296072 | B_lesional_day8 | 26.32 | 20 |
GSM1296069 | L_lesional_day8 | 35.76 | 22 |
GSM1296071 | P_lesional_day8 | 56.19 | 29 |
GSM1296070 | Y_lesional_day8 | 71.74 | 33 |
GSM1296073 | V_lesional_day8 | 69.77 | 35 |
GSM1296034 | A_lesional_day15 | 39.9 | 27 |
GSM1296041 | G_lesional_day15 | 98.2 | 40 |
GSM1296035 | R_lesional_day15 | 175.61 | 51 |
GSM1296038 | U_lesional_day15 | 64.28 | 35 |
GSM1296047 | B_lesional_day15 | 23.53 | 17 |
GSM1296039 | E_lesional_day15 | 132.66 | 46 |
GSM1296042 | H_lesional_day15 | 44.41 | 26 |
GSM1296043 | L_lesional_day15 | 74.56 | 34 |
GSM1296037 | M_lesional_day15 | 48.31 | 29 |
GSM1296046 | P_lesional_day15 | 67.04 | 32 |
GSM1296044 | Q_lesional_day15 | 13.14 | 11 |
GSM1296045 | Y_lesional_day15 | 46.31 | 25 |
GSM1296025 | C_lesional_day15 | 12.63 | 11 |
GSM1296033 | D_lesional_day15 | 9.17 | 10 |
GSM1296027 | I_lesional_day15 | 23.22 | 23 |
GSM1296032 | J_lesional_day15 | 8.5 | 9 |
GSM1296024 | K_lesional_day15 | ||
GSM1296031 | W_lesional_day15 | 24.95 | 20 |
GSM1296028 | X_lesional_day15 | 32.28 | 25 |
GSM1296029 | Z_lesional_day15 | 43.05 | 29 |
GSM1296026 | F_lesional_day15 | 89.38 | 40 |
GSM1296030 | O_lesional_day15 | 163.47 | 51 |
GSM1296040 | S_lesional_day15 | 117.37 | 43 |
GSM1296036 | T_lesional_day15 | 97.1 | 40 |
GSM1296048 | V_lesional_day15 | 115.9 | 43 |
GSM1296059 | A_lesional_day43 | 201.98 | 53 |
GSM1296066 | G_lesional_day43 | 81.82 | 36 |
GSM1296060 | R_lesional_day43 | 86.14 | 39 |
GSM1296063 | U_lesional_day43 | 64.77 | 34 |
GSM1296064 | E_lesional_day43 | 269.81 | 58 |
GSM1296067 | H_lesional_day43 | ||
GSM1296062 | M_lesional_day43 | 73.56 | 37 |
GSM1296068 | Q_lesional_day43 | 18.06 | 12 |
GSM1296050 | C_lesional_day43 | 20.19 | 16 |
GSM1296057 | D_lesional_day43 | 40.57 | 29 |
GSM1296052 | I_lesional_day43 | 9.58 | 11 |
GSM1296054 | J_lesional_day43 | 35.15 | 25 |
GSM1296049 | K_lesional_day43 | ||
GSM1296055 | W_lesional_day43 | 44.66 | 28 |
GSM1296053 | X_lesional_day43 | 53.99 | 32 |
GSM1296058 | Z_lesional_day43 | 85.76 | 40 |
GSM1296051 | F_lesional_day43 | 92.79 | 41 |
GSM1296056 | O_lesional_day43 | 510.07 | 68 |
GSM1296065 | S_lesional_day43 | 26.77 | 22 |
GSM1296061 | T_lesional_day43 | 54.6 | 31 |
GSM1296095 | A_non-lesional_pre-dose | 48.66 | 31 |
GSM1296120 | B_non-lesional_pre-dose | 6 | 5 |
GSM1296077 | C_non-lesional_pre-dose | 15.73 | 15 |
GSM1296093 | D_non-lesional_pre-dose | 55.62 | 32 |
GSM1296104 | E_non-lesional_pre-dose | 62 | 34 |
GSM1296079 | F_non-lesional_pre-dose | 25.46 | 20 |
GSM1296108 | G_non-lesional_pre-dose | 5.39 | 5 |
GSM1296110 | H_non-lesional_pre-dose | 22.02 | 16 |
GSM1296081 | I_non-lesional_pre-dose | 55.01 | 34 |
GSM1296091 | J_non-lesional_pre-dose | 31.04 | 25 |
GSM1296075 | K_non-lesional_pre-dose | 18.94 | 17 |
GSM1296112 | L_non-lesional_pre-dose | 27.12 | 17 |
GSM1296100 | M_non-lesional_pre-dose | 62.86 | 34 |
GSM1296087 | O_non-lesional_pre-dose | 48.88 | 33 |
GSM1296118 | P_non-lesional_pre-dose | 20.6 | 14 |
GSM1296114 | Q_non-lesional_pre-dose | 17.23 | 12 |
GSM1296097 | R_non-lesional_pre-dose | 16.28 | 16 |
GSM1296106 | S_non-lesional_pre-dose | 16.12 | 14 |
GSM1296102 | U_non-lesional_pre-dose | 55.62 | 32 |
GSM1296122 | V_non-lesional_pre-dose | 23.95 | 17 |
GSM1296089 | W_non-lesional_pre-dose | 55.41 | 31 |
GSM1296083 | X_non-lesional_pre-dose | 6.27 | 6 |
GSM1296116 | Y_non-lesional_pre-dose | 23.27 | 15 |
GSM1296085 | Z_non-lesional_pre-dose | 48.76 | 30 |